14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
RENX vs CDIO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Cardio Diagnostics Holdings Inc. (CDIO) is the stronger overall head-to-head candidate over RENX (RENX) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RENX carries a Unified Composite Score of 44.0/100 (HOLD) at $0.74 (N/M Forward P/E, N/A operating margin), whereas CDIO carries 47.2/100 (HOLD) at $1.60 (N/M Forward P/E, -42649.8% operating margin).
Technical & Structure Timing Caution: RENX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.6); meanwhile CDIO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RENX vs CDIO. Trailing 12-month operating profitability (RENX N/A vs CDIO -42649.8%) and valuation multiples (RENX N/M vs CDIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $4.9M market capitalization and -42649.8% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ RENX vs CDIO Key Questions & Quantitative Answers
As of Nov 20, 2026, Cardio Diagnostics Holdings Inc. (CDIO) is the stronger overall head-to-head candidate over RENX (RENX) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RENX carries a Unified Composite Score of 44.0/100 (HOLD) at $0.74 (N/M Forward P/E, N/A operating margin), whereas CDIO carries 47.2/100 (HOLD) at $1.60 (N/M Forward P/E, -42649.8% operating margin). Technical & Structure Timing Caution: RENX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.6); meanwhile CDIO is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CDIO leads the Growth & Scale pillar: RENX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CDIO at +25.7% YoY revenue growth and +0.0% YoY earnings growth on $15,185 TTM revenue (100.0% gross margin, -42649.8% operating margin). On trailing 12-month operating scale, RENX generates N/A in USD-normalized revenue versus $15,185 for CDIO. In operating R&D and SG&A reinvestment, RENX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CDIO.
RENX and CDIO trade at balanced relative valuation multiples. RENX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CDIO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RENX (N/A ROE) versus CDIO (-93.5% ROE) capital efficiency.
In options market volatility and institutional positioning, RENX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-17.85β · 161% Vol realized risk). By comparison, CDIO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.36β · 56% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.